Evidence map›Paper›PMID 35851544›Full record

ArticleLife science alliance2022

Improving the computation efficiency of polygenic risk score modeling: faster in Julia.

Annika Faucon, Julian Samaroo, Tian Ge, Lea K Davis, Nancy J Cox, Ran Tao, Megan M Shuey

Abstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Annika FauconVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Julian SamarooJuliaLab, Massachusetts Institute of Technology, Boston, MA, USA.
Tian GePsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Lea K DavisVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-5143-2282
Nancy J CoxVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-9315-0830
Ran TaoVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Megan M ShueyVanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA megan.m.shuey.1@vumc.org.ORCID 0000-0003-2866-3562

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Southeast Collaborative for Innovative Solutions to Chronic DiseasesP50MD017347 · NIMHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CARRASQUILLO, OLVEEN · 2021 to 2025
$15.5M
Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical CareR01HL151152 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Christy Leigh Avery, Jennifer Below · 2020 to 2026
$12.3M
Genetic Susceptibility and Biomarkers of Platinum-related ToxicitiesR01CA157823 · NCI · UNIVERSITY OF ROCHESTER · PI TRAVIS, LOIS B. · 2012 to 2025
$11.2M
Polygenic risk scores for cardiometabolic disorders: the role of blood cells immune response and evolutionary adaptationU01HG011720 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yun Li, ALEXANDER P REINER · 2021 to 2026
$5.4M
Automated Storage and Retrieval of Biological SystemsS10RR025141 · NCRR · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2008 to 2008
$988k
Exploring the genetic basis of AD progressionR00AG054573 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GE, TIAN · 2020 to 2022
$732k
NCATS NIH HHS UL1 TR000445NCI NIH HHS R01 CA157823NCRR NIH HHS S10 RR025141NHGRI NIH HHS U01 HG011720NHLBI NIH HHS R01 HL151152NIA NIH HHS R00 AG054573NIMHD NIH HHS P50 MD017347
6 · The paper itself

Abstract

To enable large-scale application of polygenic risk scores (PRSs) in a computationally efficient manner, we translate a widely used PRS construction method, PRS-continuous shrinkage, to the Julia programming language, PRS.jl. On nine different traits with varying genetic architectures, we demonstrate that PRS.jl maintains accuracy of prediction while decreasing the average runtime by 5.5×. Additional programmatic modifications improve usability and robustness. This freely available software substantially improves work flow and democratizes usage of PRSs by lowering the computational burden of the PRS-continuous shrinkage method.

Indexed as

Genome-Wide Association StudyMultifactorial InheritancePhenotypeRisk FactorsSoftware

Identifiers

PMID35851544
PMCPMC9297586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.